CSIMarket
 


Allovir Inc   (ALVR)
Other Ticker:  
 

Cumulative Allovir Inc 's Leverage Ratio for Trailing Twelve Months Period

ALVR's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

ALVR Leverage Ratio for Trailing Twelve Months Period

(Sep 30 2022)
III. Quarter
(Jun 30 2022)
II. Quarter
(Mar 31 2022)
I. Quarter
(Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
Y / Y Equity Growth -5.27 % -47.72 % -41.98 % -36.2 % -28.51 %
Y / Y Total Liabilities Growth -17.78 % 67.15 % 88.48 % 245.37 % 148.53 %
Leverage Ratio for Trailing Twelve Months Period 0.22 0.23 0.18 0.14 0.09
Total Ranking # 512 # 617 # 485 # 432 # 206
Seq. Equity Growth 60.13 % -17.5 % -14.91 % -15.73 % -11.63 %
Seq. Total Liabilities Growth -3.31 % 6.2 % -35.73 % 24.58 % 96.57 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to debt repayement of -3.31% Allovir Inc decreased Leverage Ratio for Trailing Twelve Months Period in the III. Quarter to 0.22, above Allovir Inc 's average Leverage Ratio for Trailing Twelve Months Period.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 64 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than Allovir Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has improved so far to 512, from total ranking in previous quarter at 617.

What is Leverage Ratio?
Who are ALVR's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 65
Sector # 288
S&P 500 # 511


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.25 0.18 0.06
(Mar 31 2021)   (Jun 30 2021)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2022, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Voyager Therapeutics Inc   0.58 
Quidelortho Corp  0.57 
Titan Pharmaceuticals inc   0.57 
Enovis Corp  0.55 
Regenxbio Inc   0.55 
Iteos Therapeutics Inc   0.55 
Eyepoint Pharmaceuticals Inc   0.54 
Biomx Inc   0.54 
Sutro Biopharma Inc   0.54 
Poseida Therapeutics Inc   0.54 
Lineage Cell Therapeutics Inc   0.54 
Sana Biotechnology Inc   0.53 
Orchard Therapeutics Plc  0.52 
Lucira Health Inc   0.49 
Biocardia Inc  0.49 
Conformis inc   0.48 
Polarityte Inc   0.47 
Denali Therapeutics Inc   0.46 
Aspira Women s Health Inc   0.46 
Bluebird Bio Inc   0.44 
Illumina Inc   0.44 
Casi Pharmaceuticals inc   0.44 
Neurocrine Biosciences Inc   0.43 
Edwards Lifesciences Corporation  0.43 
Biomerica Inc   0.42 
Hydrofarm Holdings Group Inc   0.42 
Vericel Corporation  0.41 
Berkeley Lights Inc   0.41 
Renovacor Inc   0.41 
Kodiak Sciences Inc   0.40 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

LRDC's Profile

Stock Price

LRDC's Financials

Business Description

Fundamentals

Charts & Quotes

LRDC's News

Suppliers

LRDC's Competitors

Customers & Markets

Economic Indicators

LRDC's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071